http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03066088-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bed6393c5a4910ba161144eb881e96e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19d9b6031b737a037f52ec45db0e7408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d40cbf68cd0e12a63c78720d419eb5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280d16396b7d4422a78d8ebcfe18b177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d18237c4e7eb0f2012ca9ac3193662dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aedd5b070fbe5f286327c37c894844f8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-482 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
filingDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2ec6282ee0b351d1f75807ecdccf6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4436245be25c286185c66bdedf12f1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac76395d256e4c395e8d7691f0991183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad944b40443ca727f2e22eb9378dc54a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab8a1bec3d69efd141ce49e43d0bc56e |
publicationDate | 2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-03066088-A2 |
titleOfInvention | Protease screening and novel use of proteases |
abstract | The invention relates to a novel use of certain proteases in treatment relating to the healing of wounds, especially the use thereof in fibrinolysis, collagenolysis and plasminogen activation. The invention also relates to screening methods for providing proteases suitable for the above-mentioned uses. The invention further relates to the use of proteases thus obtained, for producing a pharmaceutical composition for using in the healing of wounds, for the prophylaxis and/or treatment of myocardial infarction, thrombosis, venous thromboses, restenosis, hypoxia, ischaemia, coagulation necrosis, inflammation of the blood vessels, acute pulmonary embolism, acute and subacute arterial thromboses, fresh or old clots relating to venous thromboses, deep venous thromboses of the pelvis and the extremities, early thromboses in the region of desobliterated vessels, acute central vessel occlusion in the eye, burns and frostbite, disseminated intravesal coagulation caused by shock, acute arterial occlusion of the extremities, chronic occlusive arteriopathy, and thrombosis of arteriovenous shunts, and for treatment following a myocardial infarction, following a bypass operation, and following ballooning, for thrombolytic treatment of acute myocardial infarction, for the recanalisation of arteriovenous shunts, for the reperfusion of occluded coronary arteries relating to acute myocardial infarction, and following angioplasty with or without stent insertion. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2966734-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012056024-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9132184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9375461-B2 |
priorityDate | 2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.